Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Aeglea BioTherapeutics, Inc. (AGLE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 7.5% stake in AEGLEA BIOTHERAPEUTICS, INC. |
| 02/14/2023 |
SC 13G/A
| ORBIMED ADVISORS LLC reports a 2.9% stake in Aeglea BioTherapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| BCLS II Equity Opportunities, LP reports a 8.7% stake in Aeglea BioTherapeutics, Inc. |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/10/2023 |
SC 13G/A
| INTEGRATED CORE STRATEGIES LLC reports a 5.1% stake in AEGLEA BIOTHERAPEUTICS, INC. |
| 02/14/2022 |
SC 13G/A
| Point72 Asset Management, L.P. reports a |
| 02/14/2022 |
SC 13G/A
| BCLS II Equity Opportunities, LP reports a 5.8% stake in Aeglea BioTherapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2022 |
SC 13G/A
| ELI LILLY & Co reports a 3.1% stake in Aeglea BioTherapeutics, Inc. |
| 02/10/2022 |
SC 13G/A
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 2% stake in Aeglea Biotherapeutics, Inc. |
| 02/03/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| LV Management Group, LLC reports a 0.2% stake in Aeglea BioTherapeutics, Inc. |
| 05/08/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/06/2020 |
SC 13G/A
| PRUDENTIAL FINANCIAL INC reports a |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 6.6% stake in Aeglea BioTherapeutics, Inc. |
| 02/03/2020 |
SC 13G/A
| JENNISON ASSOCIATES LLC reports a 0% stake in Aeglea BioTherapeutics, Inc. |
| 01/30/2020 |
SC 13G/A
| Novartis Bioventures Ltd reports a 2.1% stake in Aeglea BioTherapeutics, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 7.2% stake in Aeglea BioTherapeutics, Inc. |
| 02/12/2019 |
SC 13G/A
| ORBIMED ADVISORS LLC reports a 9% stake in Aeglea BioTherapeutics, Inc. |
| 02/05/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/31/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/31/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|